Avance Clinical, the award-winning Australian led, global CRO built exclusively to service the clinical research needs of biotech companies, announced today that ...

布鲁克AVANCE III HD 系列核磁共振（NMR ）波谱仪（AVANCE III HD）300MHz­900MHz由布鲁克（北京）科技有限公司（BRUKER）提供，产地为瑞士，属于进口高场核磁共振波谱仪核磁共振，符合多项国家和国际分析标准， 布鲁克AVANCE III HD 系列核磁共振（NMR ）波谱仪（AVANCE III ...

Clinical trial findings showed Avance was noninferior to a collagen nerve cuff for returning sensory function in patients with nerve injuries in the hand. The Food and Drug Administration (FDA) has ...

Avance Biosciences has opened a 75,000-square-foot biomanufacturing facility in Northwest Houston. The facility will support the production of cell and gene therapies, vaccines, and other biologic ...

(RTTNews) - Axogen, Inc. (AXGN) announced that the U.S. Food and Drug Administration has approved the Biologics License Application (BLA) for AVANCE, an acellular nerve allograft (arwx). AXGN closed ...

ALACHUA, Fla. and TAMPA, Fla., Dec. 03, 2025 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical technologies for the restoration of ...

Avance Biosciences opened its new Potency and Cell-Based Assay Center of Excellence, a purpose-built facility designed to expand and centralize the company’s capabilities in potency and functional ...

Net loss of Avance Technologies reported to Rs 0.77 crore in the quarter ended September 2025 as against net profit of Rs 2.73 crore during the previous quarter ended September 2024. Sales declined ...

AxoGen ((AXGN)) announced an update on their ongoing clinical study. Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help ...

Avance Technologies Limited was formerly known as VMC Software Limited in 1985 and the Company name was changed to Avance Technologies Limited in March 2003. The Company operates in software related ...